These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 23650628)

  • 41. Synthesis, Radiolabeling, and Biological Evaluation of (R)- and (S)-2-Amino-5-[(18)F]fluoro-2-methylpentanoic Acid ((R)-, (S)-[(18)F]FAMPe) as Potential Positron Emission Tomography Tracers for Brain Tumors.
    Bouhlel A; Zhou D; Li A; Yuan L; Rich KM; McConathy J
    J Med Chem; 2015 May; 58(9):3817-29. PubMed ID: 25843369
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of 18F-FET PET and perfusion-weighted MR imaging: a PET/MR imaging hybrid study in patients with brain tumors.
    Filss CP; Galldiks N; Stoffels G; Sabel M; Wittsack HJ; Turowski B; Antoch G; Zhang K; Fink GR; Coenen HH; Shah NJ; Herzog H; Langen KJ
    J Nucl Med; 2014 Apr; 55(4):540-5. PubMed ID: 24578243
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radiosynthesis and Preclinical Evaluation of
    Gröner B; Hoffmann C; Endepols H; Urusova EA; Brugger M; Neumaier F; Timmer M; Neumaier B; Zlatopolskiy BD
    Mol Pharm; 2024 Jun; 21(6):2795-2812. PubMed ID: 38747353
    [No Abstract]   [Full Text] [Related]  

  • 44. Influence of Dexamethasone on O-(2-[
    Stegmayr C; Stoffels G; Kops ER; Lohmann P; Galldiks N; Shah NJ; Neumaier B; Langen KJ
    Mol Imaging Biol; 2019 Feb; 21(1):168-174. PubMed ID: 29845426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Synthesis and preliminary studies of O-(2-[18F] fluoroethyl)-L-tyrosine as a positron emission tomography imaging agent].
    Dang YH; Wang SZ; Cheng X; Zhou Q
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Aug; 24(4):370-2. PubMed ID: 12905655
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Click synthesis and biologic evaluation of (R)- and (S)-2-amino-3-[1-(2-[18F]fluoroethyl)-1H-[1,2,3]triazol-4-yl]propanoic acid for brain tumor imaging with positron emission tomography.
    McConathy J; Zhou D; Shockley SE; Jones LA; Griffin EA; Lee H; Adams SJ; Mach RH
    Mol Imaging; 2010 Dec; 9(6):329-42. PubMed ID: 21084029
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Flare Phenomenon in
    Filss CP; Schmitz AK; Stoffels G; Stegmayr C; Lohmann P; Werner JM; Sabel M; Rapp M; Goldbrunner R; Neumaier B; Mottaghy FM; Shah NJ; Fink GR; Galldiks N; Langen KJ
    J Nucl Med; 2020 Sep; 61(9):1294-1299. PubMed ID: 32005771
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of anesthetic agents and fasting duration on 18F-FDG biodistribution and insulin levels in tumor-bearing mice.
    Lee KH; Ko BH; Paik JY; Jung KH; Choe YS; Choi Y; Kim BT
    J Nucl Med; 2005 Sep; 46(9):1531-6. PubMed ID: 16157537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship of regional cerebral blood flow and kinetic behaviour of O-(2-(18)F-fluoroethyl)-L-tyrosine uptake in cerebral gliomas.
    Zhang K; Langen KJ; Neuner I; Stoffels G; Filss C; Galldiks N; Tellmann L; Rota Kops E; Coenen HH; Herzog H; Shah NJ
    Nucl Med Commun; 2014 Mar; 35(3):245-51. PubMed ID: 24240195
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter.
    Spence AM; Muzi M; Mankoff DA; O'Sullivan SF; Link JM; Lewellen TK; Lewellen B; Pham P; Minoshima S; Swanson K; Krohn KA
    J Nucl Med; 2004 Oct; 45(10):1653-9. PubMed ID: 15471829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. O-(2-[18F]-Fluoroethyl)-L-Tyrosine (FET) in Neurooncology: A Review of Experimental Results.
    Stegmayr C; Willuweit A; Lohmann P; Langen KJ
    Curr Radiopharm; 2019; 12(3):201-210. PubMed ID: 30636621
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo.
    Heiss P; Mayer S; Herz M; Wester HJ; Schwaiger M; Senekowitsch-Schmidtke R
    J Nucl Med; 1999 Aug; 40(8):1367-73. PubMed ID: 10450690
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Performance of 18F-FET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: systematic review and meta-analysis.
    Dunet V; Pomoni A; Hottinger A; Nicod-Lalonde M; Prior JO
    Neuro Oncol; 2016 Mar; 18(3):426-34. PubMed ID: 26243791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.
    Hustinx R; Lemaire C; Jerusalem G; Moreau P; Cataldo D; Duysinx B; Aerts J; Fassotte MF; Foidart J; Luxen A
    J Nucl Med; 2003 Apr; 44(4):533-9. PubMed ID: 12679396
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of animal handling on the results of 18F-FDG PET studies in mice.
    Fueger BJ; Czernin J; Hildebrandt I; Tran C; Halpern BS; Stout D; Phelps ME; Weber WA
    J Nucl Med; 2006 Jun; 47(6):999-1006. PubMed ID: 16741310
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma.
    Galldiks N; Stoffels G; Filss C; Rapp M; Blau T; Tscherpel C; Ceccon G; Dunkl V; Weinzierl M; Stoffel M; Sabel M; Fink GR; Shah NJ; Langen KJ
    Neuro Oncol; 2015 Sep; 17(9):1293-300. PubMed ID: 26008606
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dual-time-point O-(2-[(18)F]fluoroethyl)-L-tyrosine PET for grading of cerebral gliomas.
    Lohmann P; Herzog H; Rota Kops E; Stoffels G; Judov N; Filss C; Galldiks N; Tellmann L; Weiss C; Sabel M; Coenen HH; Shah NJ; Langen KJ
    Eur Radiol; 2015 Oct; 25(10):3017-24. PubMed ID: 25813014
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of D-isomers of O-11C-methyl tyrosine and O-18F-fluoromethyl tyrosine as tumor-imaging agents in tumor-bearing mice: comparison with L- and D-11C-methionine.
    Tsukada H; Sato K; Fukumoto D; Nishiyama S; Harada N; Kakiuchi T
    J Nucl Med; 2006 Apr; 47(4):679-88. PubMed ID: 16595503
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PET with O-(2-18F-Fluoroethyl)-L-Tyrosine in peripheral tumors: first clinical results.
    Pauleit D; Stoffels G; Schaden W; Hamacher K; Bauer D; Tellmann L; Herzog H; Bröer S; Coenen HH; Langen KJ
    J Nucl Med; 2005 Mar; 46(3):411-6. PubMed ID: 15750152
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Performance of 18F-FDG, 11C-Methionine, and 18F-FET PET for Glioma Grading: A Meta-analysis.
    Katsanos AH; Alexiou GA; Fotopoulos AD; Jabbour P; Kyritsis AP; Sioka C
    Clin Nucl Med; 2019 Nov; 44(11):864-869. PubMed ID: 31205150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.